Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · IEX Real-Time Price · USD
8.71
+0.31 (3.69%)
At close: Mar 28, 2024, 4:00 PM
7.68
-1.03 (-11.83%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Pulse Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
00.71.42000000
Revenue Growth (YoY)
--50.63%-------
Cost of Revenue
011.941.97000000
Gross Profit
0-11.24-0.55000000
Selling, General & Admin
15.7825.9733.8223.5222.9920.0515.53.421.62
Research & Development
27.820.8428.6426.4424.9617.259.655.512.18
Other Operating Expenses
000000.670.670.670.67
Operating Expenses
43.5746.8162.4649.9747.9537.9625.819.594.47
Operating Income
-43.57-58.06-63.01-49.97-47.95-37.96-25.81-9.59-4.47
Interest Expense / Income
-1.360.450.65-0.110.980000
Other Expense / Income
-----1.97-0.42-0.25-0.07-
Pretax Income
-42.21-58.51-63.66-49.85-46.97-37.55-25.57-9.52-4.47
Income Tax
00000000-1.66
Net Income
-42.21-58.51-63.66-49.85-46.97-37.55-25.57-9.52-2.81
Shares Outstanding (Basic)
48342823211715118
Shares Outstanding (Diluted)
48342823211715118
Shares Change
41.56%21.35%20.29%12.06%21.48%15.75%34.02%45.53%-
EPS (Basic)
-0.88-1.72-2.28-2.14-2.26-2.20-1.73-0.86-0.37
EPS (Diluted)
-0.88-1.72-2.28-2.14-2.26-2.20-1.73-0.86-0.37
Free Cash Flow
-33.16-47.41-54.53-35.81-34.79-24.17-13.64-8.12-3.4
Free Cash Flow Per Share
-0.69-1.40-1.95-1.54-1.68-1.42-0.92-0.74-0.45
Gross Margin
--1606.29%-38.79%------
Operating Margin
--8293.86%-4443.86%------
Profit Margin
--8357.86%-4489.42%------
Free Cash Flow Margin
--6773.43%-3845.84%------
EBITDA
-42.37-56.7-61.87-48.87-44.83-36.24-24.57-8.76-3.75
EBITDA Margin
--8100.29%-4363.05%------
Depreciation & Amortization
1.211.361.151.11.161.3110.760.72
EBIT
-43.57-58.06-63.01-49.97-45.99-37.55-25.57-9.52-4.47
EBIT Margin
--8293.86%-4443.86%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).